Clinical Trials
4 trialsNCT00588770 2026-05-29
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00022373 2014-10-15
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00021125 2013-06-26
Radiation Therapy in Treating Patients With Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01216800 2010-10-07
Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
National Cancer Institute (NCI)
Phase 3 Unknown